These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28536246)

  • 1. Inventive steps: the CRISPR patent dispute and scientific progress: The recent patent decisions about CRISPR tell us a lot about how advances in biology are actually made-and how they are not.
    Sherkow JS
    EMBO Rep; 2017 Jul; 18(7):1047-1051. PubMed ID: 28536246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR patent fight revived.
    Cohen J
    Science; 2019 Jul; 365(6448):15-16. PubMed ID: 31273104
    [No Abstract]   [Full Text] [Related]  

  • 3. US Supreme Court may have to settle dispute over patenting DNA sequences.
    Dyer C
    BMJ; 2011 Sep; 343():d6187. PubMed ID: 21952463
    [No Abstract]   [Full Text] [Related]  

  • 4. EPO revokes Broad's CRISPR patent.
    Harrison C
    Nat Biotechnol; 2018 Mar; 36(3):209. PubMed ID: 29509734
    [No Abstract]   [Full Text] [Related]  

  • 5. The CRISPR Patent Ruling and Implications for Medicine.
    Paradise J
    JAMA; 2023 Feb; 329(6):461-462. PubMed ID: 36637817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical and legal considerations regarding disputed authorship with the use of shared data.
    Welsh RK; Lareau CR; Clevenger JK; Reger MA
    Account Res; 2008; 15(2):105-31. PubMed ID: 18593100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How the US CRISPR patent probe will play out.
    Ledford H
    Nature; 2016 Mar; 531(7593):149. PubMed ID: 26961633
    [No Abstract]   [Full Text] [Related]  

  • 8. CRISPR patent estate splinters.
    Sheridan C
    Nat Biotechnol; 2017 Sep; 35(9):808-809. PubMed ID: 28898216
    [No Abstract]   [Full Text] [Related]  

  • 9. CRISPR heavyweights battle in US patent court.
    Reardon S
    Nature; 2016 Dec; 540(7633):326-327. PubMed ID: 27974781
    [No Abstract]   [Full Text] [Related]  

  • 10. UC granted CRISPR patents in Europe, appeals in US.
    Nat Biotechnol; 2017 May; 35(5):396. PubMed ID: 28486455
    [No Abstract]   [Full Text] [Related]  

  • 11. Use the patent system to regulate gene editing.
    Parthasarathy S
    Nature; 2018 Oct; 562(7728):486-488. PubMed ID: 30353159
    [No Abstract]   [Full Text] [Related]  

  • 12. Immaculate Conception? Priority and Invention in the CRISPR Patent Dispute.
    Sherkow JS
    CRISPR J; 2022 Apr; 5(2):174-180. PubMed ID: 35438517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why the gene patenting controversy persists.
    Eisenberg RS
    Acad Med; 2002 Dec; 77(12 Pt 2):1381-7. PubMed ID: 12480648
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR-Cas9 claim sets and the potential to stifle innovation.
    Gray BN; Spruill WM
    Nat Biotechnol; 2017 Jul; 35(7):630-633. PubMed ID: 28700549
    [No Abstract]   [Full Text] [Related]  

  • 15. The emerging patent landscape of CRISPR-Cas gene editing technology.
    Egelie KJ; Graff GD; Strand SP; Johansen B
    Nat Biotechnol; 2016 Oct; 34(10):1025-1031. PubMed ID: 27727218
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome-editing technologies and patent landscape overview.
    Benahmed-Miniuk F; Kresz M; Kanaujiya JK; Southgate CD
    Pharm Pat Anal; 2017 May; 6(3):115-134. PubMed ID: 28534435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad Institute wins bitter battle over CRISPR patents.
    Ledford H
    Nature; 2017 Feb; 542(7642):401. PubMed ID: 28230140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Will the CRISPR / CAS9 system change the genome of humanity?].
    Becú-Villalobos D
    Medicina (B Aires); 2017; 77(6):521-523. PubMed ID: 29223949
    [No Abstract]   [Full Text] [Related]  

  • 19. Who owns CRISPR-Cas9 in Europe?
    Kupecz A
    Nat Biotechnol; 2014 Dec; 32(12):1194-6. PubMed ID: 25489834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of patents and patent disputes: The TNFα patent files. Part 1: Humira.
    Storz U
    Hum Antibodies; 2017; 25(1-2):1-16. PubMed ID: 27792008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.